ORPHA:99745
Typhoid
Also known as: Typhoid fever · Typhoidal salmonellosis
Publications
83,991
Trials
59
Interventional, condition-specific
Researchers
1,135
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Typhoid or typhoid fever is a reportable, fecal-oral, potentially fatal infectious disease, caused by the bacteria Salmonella typhi and characterized by a non-focal fever.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0005619
- MeSH:D014435
- UMLS:C0041466
- NCIT:C35089
Additional Mondo synonyms (3)
typhoid · typhoid fever · typhoidal salmonellosis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
83,991 matched papers (16,959 in last 10 years) Source
- Phenotype characterisedPresent
33 HPO annotations (e.g. Decreased total leukocyte count; Constipation; Headache) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
59 matched on ClinicalTrials.gov (4 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
33
Associated phenotypes · MONDO:0005619
- Decreased total leukocyte count
- Constipation
- Headache
- Skin rash
- Splenomegaly
Showing 5 of 33 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
9
Drugs / clinical candidates · MONDO_0005619
- ALBENDAZOLE·phase 1 2
- AMPICILLIN·ind
- CIPROFLOXACIN·approval
- LEVOFLOXACIN·approval
- NALIDIXIC ACID·ind
- SECNIDAZOLE·phase 1 2
- VIBRIO CHOLERAE TOXIN B SUBUNIT·phase 1 2
- VIBRIO CHOLERAE, INACTIVATED·phase 1 2
- ZINC SULFATE·phase 1 2
CTD chemicals (MyDisease.info)
2 associated chemicals · 37 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Chloramphenicol · therapeutic
- Ciprofloxacin · therapeutic
Pathways: Phagosome; Cell adhesion molecules (CAMs); Antigen processing and presentation; Hematopoietic cell lineage; Th1 and Th2 cell differentiation; Th17 cell differentiation; Intestinal immune network for IgA production; Type I diabetes mellitus
Literature
Is anyone studying this?
83,991
83,991 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
83,991 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
16,959 in the last 10 years · low confidence
Phrase hits: 83,991 · MeSH hits: 874
Who's working on it?
1,135
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Pollard AJ10 papers · 2026
University of Oxford Oxford Vaccine Group, Oxford, England, UK.
Papers in Europe PMC - 02Garrett DO8 papers · 2026
Sabin Vaccine Institute, Washington, District of Columbia, USA.
Papers in Europe PMC - 03John J8 papers · 2026
Christian Medical College Vellore, Vellore, Tamil Nadu, India.
Papers in Europe PMC - 04Khanam F8 papers · 2026
International Centre for Diarrhoeal Diseases Research, Bangladesh, Dhaka, Bangladesh.
Papers in Europe PMC - 05Liu X8 papers · 2026
University of Oxford Oxford Vaccine Group, Oxford, England, UK.
Papers in Europe PMC - 06Qadri F8 papers · 2026
International Centre for Diarrhoeal Diseases Research, Bangladesh, Dhaka, Bangladesh.
Papers in Europe PMC - 07Andrews JR7 papers · 2026
Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
Papers in Europe PMC - 08Crump JA7 papers · 2026
University of Otago. Centre for International Health., Dunedin, New Zealand.
Papers in Europe PMC - 09Doyle K7 papers · 2026
Sabin Vaccine Institute, Washington, DC, United States of America.
Papers in Europe PMC - 10Tamrakar D7 papers · 2026
Center for Infectious Disease Research and Surveillance, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
59
interventional trials for this specific condition
59 interventional trials matched this specific condition name; 4 currently recruiting in our sample.
Data as of 11 September 2026
59 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.5th percentile).
low confidence · 97.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
59 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07641348·NOT YET RECRUITING·COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCE
Not reviewed·Conditions: Typhoid Fever·Matched via name + MeSH
- NCT06757283·NOT YET RECRUITING·ZyVac-TCV Bangladesh Study
Not reviewed·Conditions: Typhoid Vaccination · Typhoid · Typhoid Fever·Matched via name + MeSH
- NCT07286370·RECRUITING·A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
Not reviewed·Conditions: Salmonella Infections·Matched via name + MeSH
- NCT03705585·RECRUITING·CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
Not reviewed·Conditions: Typhoid and/or Cholera Vaccination·Matched via name phrase
Observational and natural-history studies
14 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06921460·NOT YET RECRUITING·Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV
Not reviewed·Conditions: Antibody Typhoid Vaccine·Matched via name phrase
- NCT04878549·RECRUITING·Transcriptomic Responses for the Identification of Pathogens
Not reviewed·Conditions: Enteric Fever · Acute Febrile Illness · Typhoid · Paratyphoid Fever·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 41 · after dedupe 41 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 41 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (41)
- isrctn·ISRCTN91882592·Recruiting·Typhoid conjugate vaccine booster study in Nepal
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11357259·Recruiting·An early safety study testing a drug combination given before possible surgery for people with pancreatic cancer that can’t be easily removed yet or hasn’t spread far
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18281619·Stopped·Typhoid conjugate vaccine booster dose study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65855590·Recruiting·Bivalent vaccination against Salmonella Typhi and Paratyphi A
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26330175·Recruiting·Understanding and managing fevers from infections spread by animals
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13151175·No longer recruiting·Mobilizing voices for science to promote trust in vaccination: the health ambassadors multi-site randomized controlled trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN99739590·No longer recruiting·First-in-human study evaluating the effect of various doses of ODM-212 in subjects with selected advanced solid tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16573769·No longer recruiting·DOMENICA: Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus dostarlimab in a first-line advanced/metastatic setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14829414·No longer recruiting·Typhoid vaccine follow-up study – Nepal
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18065452·No longer recruiting·The azithromycin and cefixime treatment of typhoid in South Asia trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15021247·No longer recruiting·Phase II study for the treatment of recurrent and/or metastatic human papillomavirus (HPV16)-associated head and neck cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51750695·No longer recruiting·Salmonella vaccine study in Oxford
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15485902·No longer recruiting·Development of a vaccine against Salmonella Paratyphi A
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60356654·No longer recruiting·Assessing optimal timing for childhood vaccines in Uganda
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN80472712·No longer recruiting·Testing IMM60 in combination with pembrolizumab in melanoma and non-small cell lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12240140·No longer recruiting·Assessing optimal timing for childhood vaccines in Nepal
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN72938224·No longer recruiting·Estimating the incidence rate of enteric (typhoid) fever in India through a multi-center surveillance network of secondary care centers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95900287·No longer recruiting·A trial to see the effect of cyclophosphamide and pembrolizumab on cancer in the kidney that has spread further into the body
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN62041885·No longer recruiting·Can giving adolescents preventive treatment for malaria, before vaccination, improve immune responses to these vaccines?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60517191·No longer recruiting·The effect of intensive treatment for schistosomiasis on response to vaccines among island adolescents in Uganda
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10482904·No longer recruiting·The impact of BCG vaccination on the response to other vaccines among Ugandan adolescents (POPVAC C)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11643110·No longer recruiting·TyVAC Bangladesh: Typhoid Vaccine Trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN43385161·No longer recruiting·TyVAC Nepal: typhoid vaccine study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78820481·No longer recruiting·Mechanisms of chronic pain and fatigue
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12131979·No longer recruiting·Understanding the burden of enteric fever in Africa and Asia: a study of transmission and antibiotic resistance to improve diagnostics and inform vaccine strategies
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Typhoid — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Typhoid" OR "Typhoid fever" OR "Typhoidal salmonellosis"
MeSH descriptor terms unioned into the query: Typhoid Fever
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Typhoid" OR "Typhoid fever" OR "Typhoidal salmonellosis"
Interventional trials matched via: both, phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 59 interventional · 14 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (83991) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T06:15:10.661Z
